Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study

Natasha B. Leighl, Matthew D. Hellmann, Rina Hui, Enric Carcereny, Enriqueta Felip, Myung Ju Ahn, Joseph Paul Eder, Ani S. Balmanoukian, Charu Aggarwal, Leora Horn, Amita Patnaik, Matthew Gubens, Suresh S. Ramalingam, Gregory M. Lubiniecki, Jin Zhang, Bilal Piperdi, Edward B. Garon

Research output: Contribution to journal › Article › peer-review